Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Vascular Dressings Market by Product Type (Antimicrobial Vascular Dressings, Non-Antimicrobial Vascular Dressings) and by End User (Hospitals, Clinics, Ambulatory Surgical Centers): Global Opportunity Analysis and Industry Forecast, 2023-2032

A12685

Pages: NA

Charts: NA

Tables: NA

Vascular dressings are also known as intravenous site dressings are used for protection of the vascular site having an injury. These are used to prevent infections that can occur at the insertion site. Since the IV sites are prone to viral and bacterial infections, these dressings are significant. Vascular dressings are not only used to prevent infection at the site but also to ensure the line in place for better management. Another common application of vascular dressings is securing surgical incisions, superficial wounds like abrasions, minor burns, and securing catheter sites. Vascular dressings aid the excess moisture to free while maintaining a moist wound healing environment which is required for healing of the wound.

COVID-19 Impact analysis

COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This in turn is expected to have a significant impact on the vascular dressings market.

Top Impacting Factors

  • Rise in cases of hospital-acquired infections at the intravenous site, increase in birth-related hospitalizations and road accidents, and surge in the geriatric population who is more prone to surgeries & hospitalization, are factors that drive the growth of the vascular dressings market.
  • In addition, increase in healthcare expenditure; availability of skilled professionals; rise in R&D activities to launch novel developed products in the market are some factors, which boost the market growth for vascular dressings.
  • However, affordability and accessibility in remote parts of the world may hinder the vascular dressings market growth.

Vascular Dressings Market Trends

New product launches to flourish the market

In 2016, Beckton Dickinson and Company and Vancive Medical Technologies launched a line of transparent vascular dressings with chlorhexidine gluconate (CHG) antimicrobial preservatives. It was intended to improve patient care and be comfortable for clinicians to apply and remove.

Key Benefits of the Report

  • This study presents the analytical depiction of the vascular dressings industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the vascular dressing’s market share.
  • The current market is quantitatively analyzed to highlight the vascular dressing’s market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the vascular dressings market.
  • The report provides a detailed vascular dressings market analysis based on competitive intensity and how the competition will take shape in coming years

Questions answered in the vascular dressings Report

  • Which are the leading players active in the vascular dressings market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the vascular dressings market?
  • What future projections would help in taking further strategic steps?
  • What is "Vascular dressings"?
  • What is "Vascular dressings" Market prediction in the future?
  • Who are the leading global players in the "Vascular dressings" Market?
  • What are the current trends and predicted trends?
  • What are the key benefits of the "Vascular dressings" Market report?

 Key Market Segments

  • By Product Type
    • Antimicrobial Vascular Dressings
    • Non-Antimicrobial Vascular Dressings
  • By End User
    • Hospitals
    • Clinics
    • Ambulatory Surgical Centers
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • 3M
  • Systagenix
  • Derma Sciences
  • Medline
  • Smith and Nephew
  • BSN Medical (Essity)
  • Reliamed
  • Vancive Medical Technologies (Avery Dennison)
  • B Braun
  • BD
  • Mölnlycke Health Care
  • Richardson Healthcare

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: VASCULAR DRESSINGS MARKET, BY PRODUCT TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product Type

    • 4.2. Antimicrobial Vascular Dressings

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Non-Antimicrobial Vascular Dressings

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: VASCULAR DRESSINGS MARKET, BY END USER

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By End User

    • 5.2. Hospitals

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Clinics

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Ambulatory Surgical Centers

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: VASCULAR DRESSINGS MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Product Type

      • 6.2.3. Market Size and Forecast, By End User

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Vascular Dressings Market

        • 6.2.5.1. Market Size and Forecast, By Product Type
        • 6.2.5.2. Market Size and Forecast, By End User

      • 6.2.6. Canada Vascular Dressings Market

        • 6.2.6.1. Market Size and Forecast, By Product Type
        • 6.2.6.2. Market Size and Forecast, By End User

      • 6.2.7. Mexico Vascular Dressings Market

        • 6.2.7.1. Market Size and Forecast, By Product Type
        • 6.2.7.2. Market Size and Forecast, By End User

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Product Type

      • 6.3.3. Market Size and Forecast, By End User

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Vascular Dressings Market

        • 6.3.5.1. Market Size and Forecast, By Product Type
        • 6.3.5.2. Market Size and Forecast, By End User

      • 6.3.6. Germany Vascular Dressings Market

        • 6.3.6.1. Market Size and Forecast, By Product Type
        • 6.3.6.2. Market Size and Forecast, By End User

      • 6.3.7. Italy Vascular Dressings Market

        • 6.3.7.1. Market Size and Forecast, By Product Type
        • 6.3.7.2. Market Size and Forecast, By End User

      • 6.3.8. Spain Vascular Dressings Market

        • 6.3.8.1. Market Size and Forecast, By Product Type
        • 6.3.8.2. Market Size and Forecast, By End User

      • 6.3.9. UK Vascular Dressings Market

        • 6.3.9.1. Market Size and Forecast, By Product Type
        • 6.3.9.2. Market Size and Forecast, By End User

      • 6.3.10. Russia Vascular Dressings Market

        • 6.3.10.1. Market Size and Forecast, By Product Type
        • 6.3.10.2. Market Size and Forecast, By End User

      • 6.3.11. Rest Of Europe Vascular Dressings Market

        • 6.3.11.1. Market Size and Forecast, By Product Type
        • 6.3.11.2. Market Size and Forecast, By End User

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Product Type

      • 6.4.3. Market Size and Forecast, By End User

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Vascular Dressings Market

        • 6.4.5.1. Market Size and Forecast, By Product Type
        • 6.4.5.2. Market Size and Forecast, By End User

      • 6.4.6. Japan Vascular Dressings Market

        • 6.4.6.1. Market Size and Forecast, By Product Type
        • 6.4.6.2. Market Size and Forecast, By End User

      • 6.4.7. India Vascular Dressings Market

        • 6.4.7.1. Market Size and Forecast, By Product Type
        • 6.4.7.2. Market Size and Forecast, By End User

      • 6.4.8. South Korea Vascular Dressings Market

        • 6.4.8.1. Market Size and Forecast, By Product Type
        • 6.4.8.2. Market Size and Forecast, By End User

      • 6.4.9. Australia Vascular Dressings Market

        • 6.4.9.1. Market Size and Forecast, By Product Type
        • 6.4.9.2. Market Size and Forecast, By End User

      • 6.4.10. Thailand Vascular Dressings Market

        • 6.4.10.1. Market Size and Forecast, By Product Type
        • 6.4.10.2. Market Size and Forecast, By End User

      • 6.4.11. Malaysia Vascular Dressings Market

        • 6.4.11.1. Market Size and Forecast, By Product Type
        • 6.4.11.2. Market Size and Forecast, By End User

      • 6.4.12. Indonesia Vascular Dressings Market

        • 6.4.12.1. Market Size and Forecast, By Product Type
        • 6.4.12.2. Market Size and Forecast, By End User

      • 6.4.13. Rest of Asia Pacific Vascular Dressings Market

        • 6.4.13.1. Market Size and Forecast, By Product Type
        • 6.4.13.2. Market Size and Forecast, By End User

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Product Type

      • 6.5.3. Market Size and Forecast, By End User

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Vascular Dressings Market

        • 6.5.5.1. Market Size and Forecast, By Product Type
        • 6.5.5.2. Market Size and Forecast, By End User

      • 6.5.6. South Africa Vascular Dressings Market

        • 6.5.6.1. Market Size and Forecast, By Product Type
        • 6.5.6.2. Market Size and Forecast, By End User

      • 6.5.7. Saudi Arabia Vascular Dressings Market

        • 6.5.7.1. Market Size and Forecast, By Product Type
        • 6.5.7.2. Market Size and Forecast, By End User

      • 6.5.8. UAE Vascular Dressings Market

        • 6.5.8.1. Market Size and Forecast, By Product Type
        • 6.5.8.2. Market Size and Forecast, By End User

      • 6.5.9. Argentina Vascular Dressings Market

        • 6.5.9.1. Market Size and Forecast, By Product Type
        • 6.5.9.2. Market Size and Forecast, By End User

      • 6.5.10. Rest of LAMEA Vascular Dressings Market

        • 6.5.10.1. Market Size and Forecast, By Product Type
        • 6.5.10.2. Market Size and Forecast, By End User

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. BD

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Vancive Medical Technologies (Avery Dennison)

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. BSN Medical (Essity)

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Richardson Healthcare

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Derma Sciences

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Mölnlycke Health Care

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Smith And Nephew

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. 3M

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. B Braun

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Systagenix

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

    • 8.11. Reliamed

      • 8.11.1. Company Overview

      • 8.11.2. Key Executives

      • 8.11.3. Company Snapshot

      • 8.11.4. Operating Business Segments

      • 8.11.5. Product Portfolio

      • 8.11.6. Business Performance

      • 8.11.7. Key Strategic Moves and Developments

    • 8.12. Medline

      • 8.12.1. Company Overview

      • 8.12.2. Key Executives

      • 8.12.3. Company Snapshot

      • 8.12.4. Operating Business Segments

      • 8.12.5. Product Portfolio

      • 8.12.6. Business Performance

      • 8.12.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL VASCULAR DRESSINGS MARKET, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL VASCULAR DRESSINGS MARKET FOR ANTIMICROBIAL VASCULAR DRESSINGS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL VASCULAR DRESSINGS MARKET FOR NON-ANTIMICROBIAL VASCULAR DRESSINGS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL VASCULAR DRESSINGS MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL VASCULAR DRESSINGS MARKET FOR HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL VASCULAR DRESSINGS MARKET FOR CLINICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL VASCULAR DRESSINGS MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL VASCULAR DRESSINGS MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. NORTH AMERICA VASCULAR DRESSINGS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. NORTH AMERICA VASCULAR DRESSINGS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 11. NORTH AMERICA VASCULAR DRESSINGS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 12. U.S. VASCULAR DRESSINGS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 13. U.S. VASCULAR DRESSINGS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 14. CANADA VASCULAR DRESSINGS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 15. CANADA VASCULAR DRESSINGS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 16. MEXICO VASCULAR DRESSINGS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 17. MEXICO VASCULAR DRESSINGS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 18. EUROPE VASCULAR DRESSINGS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 19. EUROPE VASCULAR DRESSINGS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 20. EUROPE VASCULAR DRESSINGS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 21. FRANCE VASCULAR DRESSINGS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 22. FRANCE VASCULAR DRESSINGS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 23. GERMANY VASCULAR DRESSINGS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 24. GERMANY VASCULAR DRESSINGS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 25. ITALY VASCULAR DRESSINGS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 26. ITALY VASCULAR DRESSINGS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 27. SPAIN VASCULAR DRESSINGS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 28. SPAIN VASCULAR DRESSINGS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 29. UK VASCULAR DRESSINGS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 30. UK VASCULAR DRESSINGS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 31. RUSSIA VASCULAR DRESSINGS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 32. RUSSIA VASCULAR DRESSINGS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 33. REST OF EUROPE VASCULAR DRESSINGS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 34. REST OF EUROPE VASCULAR DRESSINGS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 35. ASIA-PACIFIC VASCULAR DRESSINGS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 36. ASIA-PACIFIC VASCULAR DRESSINGS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 37. ASIA-PACIFIC VASCULAR DRESSINGS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 38. CHINA VASCULAR DRESSINGS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 39. CHINA VASCULAR DRESSINGS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 40. JAPAN VASCULAR DRESSINGS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 41. JAPAN VASCULAR DRESSINGS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 42. INDIA VASCULAR DRESSINGS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 43. INDIA VASCULAR DRESSINGS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 44. SOUTH KOREA VASCULAR DRESSINGS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 45. SOUTH KOREA VASCULAR DRESSINGS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 46. AUSTRALIA VASCULAR DRESSINGS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 47. AUSTRALIA VASCULAR DRESSINGS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 48. THAILAND VASCULAR DRESSINGS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 49. THAILAND VASCULAR DRESSINGS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 50. MALAYSIA VASCULAR DRESSINGS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 51. MALAYSIA VASCULAR DRESSINGS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 52. INDONESIA VASCULAR DRESSINGS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 53. INDONESIA VASCULAR DRESSINGS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 54. REST OF ASIA PACIFIC VASCULAR DRESSINGS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 55. REST OF ASIA PACIFIC VASCULAR DRESSINGS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 56. LAMEA VASCULAR DRESSINGS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 57. LAMEA VASCULAR DRESSINGS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 58. LAMEA VASCULAR DRESSINGS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 59. BRAZIL VASCULAR DRESSINGS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 60. BRAZIL VASCULAR DRESSINGS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 61. SOUTH AFRICA VASCULAR DRESSINGS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 62. SOUTH AFRICA VASCULAR DRESSINGS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 63. SAUDI ARABIA VASCULAR DRESSINGS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 64. SAUDI ARABIA VASCULAR DRESSINGS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 65. UAE VASCULAR DRESSINGS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 66. UAE VASCULAR DRESSINGS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 67. ARGENTINA VASCULAR DRESSINGS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 68. ARGENTINA VASCULAR DRESSINGS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 69. REST OF LAMEA VASCULAR DRESSINGS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 70. REST OF LAMEA VASCULAR DRESSINGS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 71. BD: KEY EXECUTIVES
  • TABLE 72. BD: COMPANY SNAPSHOT
  • TABLE 73. BD: OPERATING SEGMENTS
  • TABLE 74. BD: PRODUCT PORTFOLIO
  • TABLE 75. BD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 76. VANCIVE MEDICAL TECHNOLOGIES (AVERY DENNISON): KEY EXECUTIVES
  • TABLE 77. VANCIVE MEDICAL TECHNOLOGIES (AVERY DENNISON): COMPANY SNAPSHOT
  • TABLE 78. VANCIVE MEDICAL TECHNOLOGIES (AVERY DENNISON): OPERATING SEGMENTS
  • TABLE 79. VANCIVE MEDICAL TECHNOLOGIES (AVERY DENNISON): PRODUCT PORTFOLIO
  • TABLE 80. VANCIVE MEDICAL TECHNOLOGIES (AVERY DENNISON): KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 81. BSN MEDICAL (ESSITY): KEY EXECUTIVES
  • TABLE 82. BSN MEDICAL (ESSITY): COMPANY SNAPSHOT
  • TABLE 83. BSN MEDICAL (ESSITY): OPERATING SEGMENTS
  • TABLE 84. BSN MEDICAL (ESSITY): PRODUCT PORTFOLIO
  • TABLE 85. BSN MEDICAL (ESSITY): KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 86. RICHARDSON HEALTHCARE: KEY EXECUTIVES
  • TABLE 87. RICHARDSON HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 88. RICHARDSON HEALTHCARE: OPERATING SEGMENTS
  • TABLE 89. RICHARDSON HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 90. RICHARDSON HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 91. DERMA SCIENCES: KEY EXECUTIVES
  • TABLE 92. DERMA SCIENCES: COMPANY SNAPSHOT
  • TABLE 93. DERMA SCIENCES: OPERATING SEGMENTS
  • TABLE 94. DERMA SCIENCES: PRODUCT PORTFOLIO
  • TABLE 95. DERMA SCIENCES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 96. MöLNLYCKE HEALTH CARE: KEY EXECUTIVES
  • TABLE 97. MöLNLYCKE HEALTH CARE: COMPANY SNAPSHOT
  • TABLE 98. MöLNLYCKE HEALTH CARE: OPERATING SEGMENTS
  • TABLE 99. MöLNLYCKE HEALTH CARE: PRODUCT PORTFOLIO
  • TABLE 100. MöLNLYCKE HEALTH CARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 101. SMITH AND NEPHEW: KEY EXECUTIVES
  • TABLE 102. SMITH AND NEPHEW: COMPANY SNAPSHOT
  • TABLE 103. SMITH AND NEPHEW: OPERATING SEGMENTS
  • TABLE 104. SMITH AND NEPHEW: PRODUCT PORTFOLIO
  • TABLE 105. SMITH AND NEPHEW: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 106. 3M: KEY EXECUTIVES
  • TABLE 107. 3M: COMPANY SNAPSHOT
  • TABLE 108. 3M: OPERATING SEGMENTS
  • TABLE 109. 3M: PRODUCT PORTFOLIO
  • TABLE 110. 3M: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 111. B BRAUN: KEY EXECUTIVES
  • TABLE 112. B BRAUN: COMPANY SNAPSHOT
  • TABLE 113. B BRAUN: OPERATING SEGMENTS
  • TABLE 114. B BRAUN: PRODUCT PORTFOLIO
  • TABLE 115. B BRAUN: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 116. SYSTAGENIX: KEY EXECUTIVES
  • TABLE 117. SYSTAGENIX: COMPANY SNAPSHOT
  • TABLE 118. SYSTAGENIX: OPERATING SEGMENTS
  • TABLE 119. SYSTAGENIX: PRODUCT PORTFOLIO
  • TABLE 120. SYSTAGENIX: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 121. RELIAMED: KEY EXECUTIVES
  • TABLE 122. RELIAMED: COMPANY SNAPSHOT
  • TABLE 123. RELIAMED: OPERATING SEGMENTS
  • TABLE 124. RELIAMED: PRODUCT PORTFOLIO
  • TABLE 125. RELIAMED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 126. MEDLINE: KEY EXECUTIVES
  • TABLE 127. MEDLINE: COMPANY SNAPSHOT
  • TABLE 128. MEDLINE: OPERATING SEGMENTS
  • TABLE 129. MEDLINE: PRODUCT PORTFOLIO
  • TABLE 130. MEDLINE: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL VASCULAR DRESSINGS MARKET SEGMENTATION
  • FIGURE 2. GLOBAL VASCULAR DRESSINGS MARKET
  • FIGURE 3. SEGMENTATION VASCULAR DRESSINGS MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN VASCULAR DRESSINGS MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALVASCULAR DRESSINGS MARKET
  • FIGURE 11. VASCULAR DRESSINGS MARKET SEGMENTATION, BY BY PRODUCT TYPE
  • FIGURE 12. VASCULAR DRESSINGS MARKET FOR ANTIMICROBIAL VASCULAR DRESSINGS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. VASCULAR DRESSINGS MARKET FOR NON-ANTIMICROBIAL VASCULAR DRESSINGS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. VASCULAR DRESSINGS MARKET SEGMENTATION, BY BY END USER
  • FIGURE 15. VASCULAR DRESSINGS MARKET FOR HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. VASCULAR DRESSINGS MARKET FOR CLINICS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. VASCULAR DRESSINGS MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 19. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 20. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 21. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 22. COMPETITIVE DASHBOARD
  • FIGURE 23. COMPETITIVE HEATMAP: VASCULAR DRESSINGS MARKET
  • FIGURE 24. TOP PLAYER POSITIONING, 2024
  • FIGURE 25. BD: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 26. BD: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 27. BD: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 28. VANCIVE MEDICAL TECHNOLOGIES (AVERY DENNISON): NET SALES, 2022-2024 ($MILLION)
  • FIGURE 29. VANCIVE MEDICAL TECHNOLOGIES (AVERY DENNISON): REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 30. VANCIVE MEDICAL TECHNOLOGIES (AVERY DENNISON): REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 31. BSN MEDICAL (ESSITY): NET SALES, 2022-2024 ($MILLION)
  • FIGURE 32. BSN MEDICAL (ESSITY): REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 33. BSN MEDICAL (ESSITY): REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 34. RICHARDSON HEALTHCARE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 35. RICHARDSON HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 36. RICHARDSON HEALTHCARE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 37. DERMA SCIENCES: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 38. DERMA SCIENCES: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 39. DERMA SCIENCES: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 40. MöLNLYCKE HEALTH CARE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 41. MöLNLYCKE HEALTH CARE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 42. MöLNLYCKE HEALTH CARE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 43. SMITH AND NEPHEW: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 44. SMITH AND NEPHEW: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 45. SMITH AND NEPHEW: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 46. 3M: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 47. 3M: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 48. 3M: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 49. B BRAUN: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 50. B BRAUN: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 51. B BRAUN: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 52. SYSTAGENIX: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 53. SYSTAGENIX: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 54. SYSTAGENIX: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 55. RELIAMED: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 56. RELIAMED: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 57. RELIAMED: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 58. MEDLINE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 59. MEDLINE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 60. MEDLINE: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Vascular Dressings Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved